申请人:BELLICUM PHARMACEUTICALS INC
公开号:WO2019126344A1
公开(公告)日:2019-06-27
The technology relates in part to compounds that bind to multimeric ligand binding regions, referred to herein as "multimeric compounds." In certain examples, the multimeric compounds provided herein bind to and multimerize polypeptides that bind to rimiducid, such as for example, chimeric polypeptides that comprise FKBP12 polypeptide variant regions. Multimeric compounds provided include those having a structure of Formula I. Where A, Z, Y, Z' and A' moieties are described herein.
这项技术部分涉及与多聚配体结合区域相关的化合物,本文中称为“多聚化合物”。在某些示例中,本文提供的多聚化合物结合并多聚化与rimiducid结合的多肽,例如包含FKBP12多肽变体区域的嵌合多肽。所提供的多聚化合物包括具有Formula I结构的化合物。其中A、Z、Y、Z'和A'基团在本文中有所描述。